You are here

AusPAR: Fremanezumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

24 January 2020
AusPAR Details
AusPAR
Active Ingredient
Fremanezumab
Product Name
Ajovy
Sponsor
Teva Pharma Australia Pty Ltd
Submission Number
PM-2018-03494-1-1
Submission Type
New biological entity
Decision
Approved
AusPAR Date
18 December 2019
Publication Date

24 January 2020